Zelira Therapeutics Limited

Short Term Long Term Short Term Comparison Long Term Comparison
  • ZLD
  • 1d2.90%
  • 1w2.16%
  • 1m-2.74%
  • 1y-31.07%
ATH
  • ATH Price$20,052.10
  • ATH Date2006-04-26
  • % since ATH-100.00%
  • % to ATH2,824,139.44%
ATL
  • ATL Price$0.69
  • ATL Date2024-04-02
  • % from ATL3.65%
  • Last Low Price$0.685
  • Last Low Date2024-04-02
  • % From Last Low3.65%
IPO
  • IPO Price$0.20
  • % Current ROI USD355.00%
  • ATH Price$20,052.10
  • % ROI ATH 292,731,386.86%
[addtoany]

Graph takes few seconds to load...

[financial_chart symbol="ZLD"]

Key Data [addtoany]

Current price $0.71
Sector Healthcare
Industry Biotechnology
Today's High/Low $0.75/$0.69
Volume 3,516.00
Previous Close $0.69
52 Week High/Low $3.35/$0.68
Market Cap 7,829,568.00
P/E Ratio 0
Forward P/E 1 Yr. $0.00
Earnings Per Share(EPS) $0
Annualized Dividend $0
$0.71
[addtoany]

Zelira Therapeutics Limited, a bio-pharmaceutical company, engages in the development of cannabinoid-based formulations for the treatment of various medical conditions in Australia.
It offers formulations under the HOPE brand in Pennsylvania and licenses in Louisiana, as well as develops Zenivol, a cannabinoid-based medicine for treatment of chronic insomnia.
The company is also involved in a human clinical trial program focused on insomnia, autism, and opioid reduction; and a pre-clinical research program to examine the effect of cannabinoids in breast, brain, and pancreatic cancer, as well as the potential for cannabinoid formulations to treat diabetes-associated cognitive decline.
It has a strategic partnership with CannPal Pty Ltd; and St Vincent’s Hospital on opioid reduction study.
The company was formerly known as Zelda Therapeutics Limited and changed its name to Zelira Therapeutics Limited in December 2019.
Zelira Therapeutics Limited is based in Perth, Australia.

Annual Data | Millions of US $ except per share data
Cash on hand
Receivables
Inventory
Pre-Paid Expenses
Other Current Assets
Total Current Assets
Property, Plant, And Equipment
Long-Term Investments
Goodwill And Intangible Assets
Other Long-Term Assets
Total Long-Term Assets
Total Assets
Total Current Liabilities
Long Term Debt
Other Non-Current Liabilities
Total Long Term Liabilities
Total Liabilities
Common Stock Net
Retained Earnings (Accumulated Deficit)
Comprehensive Income
Other Share Holders Equity
Share Holder Equity
Total Liabilities And Share Holders Equity